All sponsors

Philogen S.p.A.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS10
PHASE 3 / 2-32
RECRUITING6
READOUTS ≤12 MONTHS0
READOUT SLIPPED >6 MO25%

Delay Index: of 8 active trials registered more than a year ago, 2 have moved their primary completion (readout) date by more than 6 months since first registration (median +2.0 months). See all sponsors →

Open Philogen S.p.A. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Pivotal
NCT02938299
P3Active, not recruitingMalignant Melanoma2142024-10
FLASH
NCT04733183
P2Active, not recruitingSoft Tissue Sarcoma982025-12 (+24 mo)
GLIOSTELLA
NCT06336291
P2Active, not recruitingGlioblastoma902026-06
GLIOSUN
NCT04443010
P1/2RecruitingGlioblastoma2262026-10
NeoDREAM
NCT03567889
P3RecruitingMelanoma Stage IIIB; Melanoma Stage IIIC1862027-12 (+90 mo)
INTACT/MeRCI
NCT06284590
P2RecruitingMelanoma Stage III; Melanoma Stage IV1622028-07
IMAGLIO
NCT07120984
P2Not yet recruitingGlioma522029-01-30
L19IL2/L19TNF
NCT07228442
P2RecruitingLocally Advanced Cutaneous Squamous Cell Carcinoma922031-02 (+2 mo)
L19IL2
NCT07227350
P2RecruitingLocally Advanced Basal Cell Carcinoma1802031-02 (+2 mo)
L19IL2/L19TNF
NCT07227870
P2RecruitingLocally Advanced Basal Cell Carcinoma922031-02 (+2 mo)